Arax Advisory Partners
BNTC icon

Arax Advisory Partners’s Benitec Biopharma BNTC Stock Holding History

Arax Advisory Partners’s Portfolio BNTC Stock Details BNTC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$3.33K Buy
+249
New +$2.95K ﹤0.01% 4696
2025
Q4 		– Sell
-24
Closed -$337 – 4127
2025
Q3 		$337 Buy
+24
New +$306 ﹤0.01% 3407

Other funds holding BNTC

Suvretta Capital Management
Suvretta Capital Management New York $5.47B AUM 131.34% 1-Year Est. Return
Jupiter Topco
Jupiter Topco New York $245B AUM
Franklin Resources
Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $71.3B AUM 56.8% 1-Year Est. Return
RA Capital Management
RA Capital Management Boston, Massachusetts $11.5B AUM 168.77% 1-Year Est. Return
Nantahala Capital Management
Nantahala Capital Management New Canaan, Connecticut $3.01B AUM 119.46% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Simplify Asset Management
Simplify Asset Management Las Vegas, Nevada $7.19B AUM 6.88% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
IAM
Infinitum Asset Management Fort Lauderdale, Florida $983M AUM 26.53% 1-Year Est. Return

Arax Advisory Partners's BNTC Position: Q2 2026 in Review

Arax Advisory Partners opened a new position in Benitec Biopharma (BNTC) in Q2 2026: 249 shares worth $3.33K. The stake represents ﹤0.01% of the portfolio and ranks #4696 among its holdings. This is a return to the name: Arax Advisory Partners previously reported a position in BNTC as recently as Q3 2025.

Arax Advisory Partners first reported a position in BNTC in Q3 2025 and has held it in 2 quarters since. 86 funds tracked by Wall St. Rank hold BNTC as of Q2 2026.

  • Arax Advisory Partners held 249 shares of Benitec Biopharma worth $3.33K as of Q2 2026.
  • Benitec Biopharma was a new Arax Advisory Partners position in Q2 2026.
  • Benitec Biopharma made up ﹤0.01% of Arax Advisory Partners's portfolio in Q2 2026, its #4696 holding.
  • Arax Advisory Partners first reported a position in Benitec Biopharma in Q3 2025 and has held it in 2 quarters since.
  • 86 funds tracked by Wall St. Rank held Benitec Biopharma as of Q2 2026.

Based on Arax Advisory Partners's 13F filing for Q2 2026, filed 10 Aug 2026.